Journals / MN Oftalmoloji / 2014 / Cilt: 21 - Sayı: 2

Sjogren syndrome and lipid keratopathy

Sjögren sendromu ve lipid keratopati

Pages
138–140
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Dry eye disease that can lead to serious complications should be treated with caution and follow-up should be done in an orderly manner.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The purpose of this paper is to report a case of bilateral secondary lipid keratopathy and corneal vascularization as a result of Sjogren syndrome.
📊
Key Findings & Data:A 38-year old woman was referred to our clinic with bilateral corneal opacity, ocular irritation and photophobia for 1 year.
💡
Conclusion & Impact:Dry eye disease that can lead to serious complications should be treated with caution and follow-up should be done in an orderly manner.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

The purpose of this paper is to report a case of bilateral secondary lipid keratopathy and corneal vascularization as a result of Sjogren syndrome. A 38-year old woman was referred to our clinic with bilateral corneal opacity, ocular irritation and photophobia for 1 year. She had a history of Sjogren syndrome for 10 years and dry eye treatment with eye drops for 8 years. Permanent punctal occlusion had been performed 7 years ago in both eyes. For treatment Cyclosporine A, %0.05 (Restasis, Allergan) (CSA) was added to treatment twice a day, along with artificial tears. After 6 months all symptoms and signs other than lipid accumulation and corneal vascularization got better. Dry eye disease that can lead to serious complications should be treated with caution and follow-up should be done in an orderly manner.

Özet

Bu yazının amacı, Sjögren sendromu nedeniyle oluşan korneal neovaskülerizasyon ve se- konder lipid keratopatili bir olguyu sunmaktır. 38 yaşındaki kadın hasta bilateral korneal opasite ve 1 yıldır şiddeti artmış oküler iritasyon ve fotofobi ile kliniğimize sevk edildi. Hasta 10 yıl önce Sjögren sendromu tanısı almıştı ve 8 yıldır da kuru göz nedeniyle suni gözyaşı kul- lanıyordu. Her iki göze 7 yıl önce kalıcı punktum oklüzyonu yapılmıştı. Günde iki kez siklos- porin A %0,05 (Restasis, Allergan) (CSA) kullandığı suni gözyaşına eklendi. 6 ay sonrası tüm semptomları, lipid birikimi ve korneal vaskülerizasyon dışındaki tüm bulguları geriledi. Ciddi komplikasyonlara yol açabilecek kuru göz hastalığı dikkatli tedavi edilmeli ve takipleri düzenli bir şekilde yapılmalıdır.

🔖

Cite This Article

AKDEMİR, M. O., SAYMAN, I. B. M., KANDEMİR, B. (2014). Sjogren syndrome and lipid keratopathy. MN Oftalmoloji, Cilt: 21 - Sayı: 2, 138–140. https://ajindex.com/articles/295683

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (8)

  1. Cogan DG and Kuwabara T:Lipid keratopathy and atheroma. Circulation 1958:18;519
  2. Richard I. Chang, Steven Ching. Lipid Degeneration. In: Krachmer JH, 3rd ed. Cornea,Vol 1. Corneal and Conjonktival Degenerations. St. Louis: Mosby 2011:902
  3. Ghanem RC, Ghanem VC, Victor G, Alves MR. Bilateral pro- gressive idiopathic annular lipid keratopathy. Case Rep Ophthalmol Med 2012;2012:731413
  4. Tavares Fde P, Fernandes RS, Bernardes TF, Bonfioli AA, Soares EJ. Dry eye disease. Semin Ophthalmol 2010; 25(3):84-93
  5. Research in dry eye: report of the Research Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf 2007 Apr;5 (2):179-93
  6. Murube J. Triple classification of diagnosis of dry eyes. Ocul Surf 2008;6:61-9
  7. Alfonso E, Arrellanes L, Boruchoff SA, Ormerod LD, Albert DM. Idiopathic bilateral lipid keratopathy. Br J Ophthalmol 1988 May;72(5):338-43
  8. D.F. Savino, B.S. Fine, O.C. Alldredge. Primary lipidic degen- eration of the cornea. Cornea, 1986; 5(4);191-198 9. Pillai CT, Dua HS, Hossain P: Fine needle diathermy occlu- sion of corneal vessels. Invest Ophthalmol Vis Sci 2000; 41(8):2148 10. Oh JY, Kim MK, Wee WR. Subkonjonktival and intracorneal bevacizumab injection for corneal neovascularization in lipid keratopathy. Cornea 2009;28:1070-3.